2009.10.17 Weekly Broadcast Email
The following updates were made to the website for the week of October 12, 2009.
91105: Phase III Double Blind, Placebo Controlled Study of Donepezil in Irradiated Brain Tumor Patients
Amendment 8 has been added to the website. This amendment includes changes to the protocol, consent and appendices 2, 12, 13, 14 and 16.
97106 (Randomized Study to Determine whether ArginMax Improves the Sexual Function and Quality of Life in Female Cancer Survivors) only has 9 minority accrual slots open for patient accruals. We would like to see this study close by the end of the summer, so if you have patients that may be eligible for this study, please try and get them registered by then.